Literature DB >> 27367444

The promise of adaptive radiotherapy for pelvic tumors: "too high cost for too little result" or "a low cost for a significant result"?

Claudio Fiorino1, Cesare Cozzarini2, Paolo Passoni2.   

Abstract

Entities:  

Year:  2016        PMID： 27367444     DOI： 10.1080/0284186X.2016.1203460

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  3 in total

1.  Factors influencing the use of adaptive radiation therapy in vulvar carcinoma.

Authors:  Fawzi Abuhijla; Samer Salah; Maysa Al-Hussaini; Issa Mohamed; Imad Jaradat; Abdulmajeed Dayyat; Hanan Almasri; Alaa Allozi; Ayah Arjan; Abdelatif Almousa; Ramiz Abu-Hijlih
Journal:  Rep Pract Oncol Radiother       Date:  2020-07-10

2.  Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index.

Authors:  Claudio Fiorino; Paolo Passoni; Anna Palmisano; Calogero Gumina; Giovanni M Cattaneo; Sara Broggi; Alessandra Di Chiara; Antonio Esposito; Martina Mori; Monica Ronzoni; Riccardo Rosati; Najla Slim; Francesco De Cobelli; Riccardo Calandrino; Nadia G Di Muzio
Journal:  Clin Transl Radiat Oncol       Date:  2019-07-03

3.  Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy.

Authors:  Miriam Eckl; Gustavo R Sarria; Sandra Springer; Marvin Willam; Arne M Ruder; Volker Steil; Michael Ehmann; Frederik Wenz; Jens Fleckenstein
Journal:  Radiat Oncol       Date:  2021-08-04       Impact factor: 3.481
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.